Systemic In Utero Gene Editing As a Treatment for Cystic Fibrosis

Researchers demonstrated cystic fibrosis (CF) transmembrane conductance regulator gene correction in multiple tissues affected by CF after a single in utero administration of nanoparticles containing gene editing cargo.